T-Therapeutics is a platform that improves the immune system's precision in targeting diseased cells while sparing healthy tissue.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€27,500,000
Total raised
-
Valuation
63
Employees
2022
Founded
Latest round
Series A - November 13, 2025
Series A - €27,500,000
November 13, 2025 · Read the story
Not named in the source article
Open roles
T-Therapeutics is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile